Each material 8-K filed by a company listed on a US stock exchange (NYSE, Nasdaq, Cboe), read and summarized: what happened, the key numbers, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). This page lists the last 45 days; every brief stays on its company's 8-K page (1654 companies, A–Z).
Hyperscale Data entered a note purchase agreement dated November 6, 2026 with an institutional investor for convertible notes with an aggregate face amount of $27,027,027.03, including original issue discount. The first note closed the same day, and the notes convert into Class A common stock at a discount to market price, which could dilute existing shareholders.
Initial note: $10,810,810.81 principal for a $10,000,000 purchase price, closed November 6, 2026
Second note: $5,405,405.41 principal for a $5,000,000 purchase price, expected on or around November 16, 2026
Conversion at the lower of $0.30 or a 10% discount to the lowest 5-day VWAP, with a $0.1025 floor; issuance capped at 19.99% of outstanding shares unless stockholders approve
Notes accrue 8% interest and mature February 5, 2027, extending to May 5, 2027 after stockholder approval
RenX Enterprises exchanged $1,022,971.22 of principal and accrued interest under a February 12, 2026 senior convertible note for a new senior convertible note of $1,037,283.93 and a warrant to buy 644,944 shares, both issued November 2, 2026. The new note carries 10% interest and a 12-month maturity, and it can convert at $2.895 per share, with a possible alternate conversion price tied to a $0.534 floor once stockholders approve, which could add substantial share issuance for existing holders.
Exchanged $1,022,971.22 of the February 12, 2026 note for a new note of $1,037,283.93, equal to 110% of the prior note's outstanding principal.
New note bears 10% interest, matures in 12 months, and has an initial conversion price of $2.895 per share.
Alternate conversion, available after stockholder approval, is priced at the greater of a $0.534 floor and 92% of the lowest 10-day VWAP.
Warrant has a $2.67 exercise price and a six-year term; default interest rises to 18% per annum if an event of default occurs.
Silo Pharma, Inc. entered into securities purchase agreements on November 5, 2026, and closed a private placement with accredited investors on November 6, 2026. The company expects net proceeds of approximately $815,000 for working capital and general corporate purposes, and it agreed to register the resale of the shares and warrant shares with the SEC, which adds potential future share supply for existing shareholders.
Sold 136,005 shares of common stock at $1.50 per share
Issued pre-funded warrants for up to 430,661 shares of common stock at $1.4999 per warrant
Expected net proceeds of approximately $815,000 after placement agent fees and offering expenses
Must file a resale registration statement within 30 days of the November 5, 2026 registration rights agreement, with effectiveness targeted within 60 days (90 days if the SEC conducts a full review)
Reed's, Inc. entered into a third amendment to its senior secured loan with Whitebox-affiliated lenders and Cantor Fitzgerald, adding new liquidity and equity-contribution conditions. The company must receive at least $2,500,000 in cash equity contributions by November 20, 2026, or an Event of Default will occur, and it must also pay a $25,000 extension fee by that date. The company said a delay in its previously announced private placement pushed the expected closing to on or before November 20, 2026, and it has so far received $7,500,000 in gross proceeds from that placement.
Minimum liquidity covenant of not less than $11,000,000 in Cash / Inventory / AR Liquidity, tested at any time and monthly after the Increased Liquidity Period
New Event of Default if at least $2,500,000 in cash equity contributions is not received by November 20, 2026
Non-refundable $25,000 extension fee due on or before November 20, 2026; nonpayment is an Event of Default
Private placement agreement dated October 28, 2026; $7,500,000 gross proceeds received to date
Health In Tech, Inc. issued a second promissory note to investor YA II PN, Ltd. on November 2, 2026, with a principal amount of $3.0 million, which provided gross proceeds of $2.85 million after a 5% purchase price discount. The notes are convertible into Class A common stock at a fixed price of $1.5735 per share and can be converted into shares that could dilute existing holders, with an Exchange Cap of 13,100,378 shares that the company is seeking stockholder approval to exceed at its November 10, 2026 annual meeting.
Second promissory note issued November 2, 2026: $3.0 million principal, $2.85 million gross proceeds after 5% discount
Notes mature February 18, 2028, bear 8.75% annual interest (18% after certain defaults), and carry a 4% payment premium unless paid via stock sale proceeds
Conversion price fixed at $1.5735 per share with a floor price of $0.204; Exchange Cap is 13,100,378 shares, about 19.99% of outstanding Class A and Class B common stock
Company seeks stockholder approval to issue shares above the Exchange Cap at its annual meeting on November 10, 2026
Profusa, Inc. entered into Amendment No. 4 to its Note Modification and Conversion Agreement with holder NorthView Sponsor I LLC on November 5, 2026. The amendment sets a $0.20 floor on the conversion price for the note, which has an original principal amount of up to $2,500,000. The change could result in a larger number of shares being issued to the holder on conversion, which may dilute existing shareholders.
Amendment No. 4 dated November 5, 2026 sets conversion price at the greater of $0.20 Floor Price or the prior trading day's Nasdaq closing price
Conversion shares are calculated as principal multiplied by 122%, divided by the conversion price, unchanged by the amendment
The prior Amendment No. 3 of August 12, 2026 set the conversion price at the greater of $4.28 or the prior trading day's closing price
Original note principal amount of up to $2,500,000, with the agreement first entered April 24, 2026
MediaCo Holding entered a Third Amendment to its First Lien Term Loan Credit Agreement, moving the maturity of its Delayed Draw Term Loans from October 31, 2026 to the earliest of November 30, 2026 or certain acceleration or debt-related triggers. The lender agent acknowledged that defaults or events of default have occurred and are continuing, and all parties reserved their rights, signaling significant financial stress for shareholders.
Delayed Draw Term Loan maturity extended from October 31, 2026 to no later than November 30, 2026
Agent acknowledged that certain defaults or events of default have occurred and are continuing
Agent and lenders reserved all rights and remedies under the Credit Agreement
Company released the agent and lenders from known claims arising on or before the amendment date
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Frequently asked questions
Which filings get a brief?
Form 8-K filings by companies listed on a US stock exchange (NYSE, Nasdaq, Cboe; not over-the-counter stocks) that report a material event: results (Item 2.02), deals (1.01, 2.01), executive changes (5.02), restructuring (2.05), impairments (2.06), delisting notices (3.01), restatements (4.02), cybersecurity incidents (1.05), bankruptcy (1.03) and Regulation FD or other events (7.01, 8.01). Routine filings such as vote results or exhibits only are skipped.
How is the impact score set?
The AI rates each filing from 1 (routine) to 5 (major, such as a merger, bankruptcy or restatement) based only on what the filing says. It is a reading aid for sorting the day's filings, not a prediction of how the stock will move.
How quickly do briefs appear?
On weekdays the SEC filing feed is checked every 5 minutes from 6 am to 5:45 pm Eastern, when nearly all 8-Ks come in, and every hour after that until 10 pm. Briefs of the 1,000 largest companies follow within minutes; the others usually within the hour, or later the same day when many filings arrive at once.
Which companies are covered?
Every company with shares listed on the NYSE, Nasdaq or Cboe that files 8-Ks, about 4,500 of them. Foreign companies that report on Form 6-K instead are not included. The S&P 1500 only filter above narrows the list to the large, mid and small caps of the S&P Composite 1500.
Are older briefs kept?
Yes. This page shows the last 45 days, but every brief ever published stays online: each has its own page, and each company has an 8-K page listing all of its briefs, newest first, linked from its stock page and from the A-Z list of companies.